-+ 0.00%
-+ 0.00%
-+ 0.00%

Camp4 Therapeutics director Andrew J. Schwab disposes of 10 shares worth $45

PUBT·08/26/2026 20:58:32
Listen to the news
Camp4 Therapeutics director Andrew J. Schwab disposes of 10 shares worth $45
  • Camp4 Therapeutics director Andrew J. Schwab reported a sale of 10 common shares at USD 4.5 on Aug. 24, 2026.
  • 5AM Ventures VI’s stake fell to 2,433,270 shares held indirectly following the transaction.
  • Schwab also reported indirect holdings of 2,941,176 shares via 5AM Ventures VII and 302,770 shares via 5AM Opportunities II.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001598549-26-000009), on August 26, 2026, and is solely responsible for the information contained therein.